63 studies found for:    Open Studies | "Hair Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hair Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting EValuation of the Impact of a TOpical Lotion on Permanent Chemotherapy Induced Hair Disorders in Cancer Survivors
Condition: Alopecia
Interventions: Other: CG428;   Other: Placebo
2 Not yet recruiting Point-of-Care Adipose-derived Cells for Hair Growth
Condition: Androgenetic Alopecia
Interventions: Procedure: Stromal Vascular Fraction Cells (SVF Cells) Injection;   Procedure: Liposuction;   Other: Hair Measurements
3 Not yet recruiting Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia
Condition: Androgenic Alopecia
Interventions: Drug: DA-4001 H;   Drug: DA-4001 L
4 Not yet recruiting Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis
Intervention: Drug: Tofacitinib ointment
5 Recruiting "Impact of Chemotherapy-induced Alopecia on the Quality of Life of Women With Breast Cancer"
Condition: Chemotherapy-induced Alopecia
Intervention: Behavioral: Semi-structured interviews
6 Recruiting Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth
Conditions: Hypertrichosis;   Alopecia;   Hirsutism
Interventions: Drug: FOL-005;   Other: Placebo
7 Recruiting Photosensitization Study in Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Drug: Finasteride 0.25%;   Drug: Placebo for Finasteride 0.25%;   Drug: Negative Control
8 Not yet recruiting Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Condition: Alopecia
Interventions: Drug: setipiprant;   Drug: placebo;   Drug: finasteride
9 Recruiting Topical Garlic Concentrate for Alopecia Areata in Children
Condition: Alopecia Areata
Intervention: Drug: garlic concentrate
10 Recruiting A Randomized Placebo-controlled Single Center Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Apremilast;   Drug: Placebo
11 Recruiting A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Tralokinumab;   Drug: Placebo
12 Recruiting Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
Conditions: Alopecia;   Alopecia, Androgenetic;   Baldness
Intervention: Drug: Bimatoprost
13 Not yet recruiting Safety and Efficacy Study of SHAPE Gel in Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: SHAPE Gel
14 Recruiting Adipose-derived SVF for Treatment of Alopecia
Condition: Androgenetic Alopecia
Intervention: Device: GID SVF-2
15 Recruiting Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females
Condition: Alopecia Areata
Intervention: Other: MEXIS/M6S Patent - lotion against alopecia
16 Recruiting A Study of Secukinumab for the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Secukinumab;   Drug: Placebo
17 Recruiting Hair Fall in Patients on Low Dose Methotrexate
Conditions: Alopecia;   Rheumatoid Arthritis;   Methotrexate Adverse Reaction
Intervention:
18 Not yet recruiting Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment
Condition: Androgenetic Alopecia
Interventions: Device: Autologous Platelet Rich Plasma;   Device: Saline solution injection
19 Recruiting LEO 124249 Ointment in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: LEO 124249;   Other: Vehicle
20 Recruiting TREg Activation in the Treatment of the PELADE (Alopecia Areata)
Condition: Alopecia Areata
Interventions: Drug: IL2;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years